Altogether, this study demonstrates: (1) FXR directly regulates ACE2 expression; (2) ACE2 levels closely associate with SARS-CoV-2 entry; (3) UDCA could be used as a prophylaxis or a therapy for COVID-19.110. The gene discussed is ACE2; the disease is COVID-19.